Community/Retail

Somatrogon-ghla (Ngenla; Pfizer Inc, OPKO Health Inc) is a subcutaneous injection that is administered once weekly via a device allowing for titration based on patients’ needs.

The recommended addition is based on a uniform consensus that the therapy is an appropriate treatment for this difficult-to-treat disease.

Cases highlight patients who have attention-deficity/hyperactivity disorder and diabetic peripheral nephropathy.

As the battle over abortion rages, mifepristone has become the new center of the legal fight between anti-abortion advocates and the FDA.

Includes hair growth supplements and nicotine lozenges.

OTC cases focus on recommendations for vaccination boosters and managing fever.

The growing volume of drugs sold through illegal online pharmacies are estimated to generate 10 times higher adverse event rates than drugs sold through legal pharmacies.

Evidence shows vitamin D deficiency is linked to abnormal dopamine signaling disorders in neurodevelopment, including schizophrenia.

The NCPA Convention will be held from October 14, 2023 through October 17, 2023, in Orlando, Florida.

Pharmacies should start to prepare for cash flow challenges when the direct and indirect remuneration changes in 2024.

This approval makes ritlecitinib, in the 50 mg dosage, the first and only treatment approved by the FDA for adolescents aged 12 years and older with severe alopecia areata.

Liam Volk, MPharm, discussed the recent end of the FDA’s ban on gay and bisexual men donating blood, saying it’s a good step, although more must be done.

The results of the study were presented at the 83rd Scientific Sessions of the American Diabetes Association in San Diego, California and were also published in The Lancet.

The American Diabetes Association showcased advancements in diabetes technology revolving around improving glucose control devices and treating diabetic retinopathy at the 83rd Scientific Sessions.

During separate panel discussions at McKesson ideaShare 2023, pharmacists discussed advocacy for pharmacy benefit manager reform and community health worker training.

McKesson also announced the rollout of the Foster & Thrive program and a new Ohio distribution center during the conference.

Pharmacists can recognize evidence of successful interventions and learn how to integrate them into their own practice.

Body mass index fails to account for differences in race, ethnicity, age, sex, and other factors, and has a history of use for racist exclusion.

Several workplace risk factors, including safety concerns going unaddressed, predicted suicidal thoughts.

Model produces information that can lead to individual providers identifying women who may need more targeted and more frequent HIV testing or be good candidates for preexposure prophylaxis.

Although second-generation antihistamines are preferred, patient preference should drive selection of therapy.

As the COVID-19 Public Health Emergency and PREP Act Expansions end, the ability of technicians to immunize patients in the future remains unclear.

Access, diagnosis, and treatment for BIPOC patients suffering from migraines is yet another unflattering reflection of the lack of health equity in the United States.

Community health workers can address issues of health equity to enhance the services of the pharmacy and support a value-based care model.

Health Mart is offering a new basic training program with ASHP/ACPE accreditation for pharmacy technicians, along with accredited and non-accredited training.

Pharmacists play key roles in performing comprehensive patient reviews, reducing polypharmacy.

Christina Madison, PharmD, FCCP, AAHIVP, sat down with Sandra Leal, PharmD, MPH, FAPhA, CDCES, vice president of pharmacy practice innovation and advocacy at CVS Pharmacy, to discuss how pharmacists are diving into public health and expanding their roles.

Guilty plea relates to shortcomings in recordkeeping of controlled substances 10 years earlier.

Utilizing longitudinal assessments of language impairment and clinical progression could help identify challenges earlier.

CDC Advisory Committee on Immunization Practices recommends the use of respiratory syncytial virus (RSV) vaccine, adjuvanted (Arexvy) for adults 60 years of age and older based on findings from the first season of the pivotal AReSVi-006 (Adult Respiratory Syncytial Virus) phase III trial.